RSV activity in Ireland
Current respiratory syncytial virus (RSV) activity in Ireland, based on ECDC ERVISS weekly data from the Health Protection Surveillance Centre (HPSC).
Influenza: Low
Low
The source currently reports no meaningful activity (as of 16 Aug 2026).
Data window: Week 33 · Aug 10 – Aug 16 · Source: ECDC (weekly) · Source on seasonal break, next data from week 40
Get one free alert when the wave turns in Ireland
We write exactly once: the moment the level goes up. No account, no newsletter. We store your address and the country, nothing else. Every mail has a one click unsubscribe. Privacy
View the last 8 weeks
In week 33 of 2026, Influenza activity in Ireland is classified as low.
The source reports no meaningful activity across these weeks; a week-over-week percentage would be pure noise here.
The last 8 reported weeks
| Week | Relative | Level | vs prior week |
|---|---|---|---|
| Week 33 | – | Low | – |
| Week 32 | – | Low | – |
| Week 31 | – | Low | – |
| Week 30 | – | Low | – |
| Week 29 | – | Low | – |
| Week 28 | – | Low | – |
| Week 27 | – | Low | – |
| Week 26 | – | Low | – |
Across these weeks the source reports no meaningful activity, the values sit at the floor of its scale.
Current activity
- InfluenzaLowstableWeek 33Trend: stable · Week 33
- COVID-19LowrisingWeek 33Trend: rising · Week 33
- RSVLowstableWeek 33Trend: stable · Week 33
What this means
In week 33 of 2026, activity of respiratory syncytial virus (RSV) in Ireland is low. The trend, derived from clinical surveillance, is stable.
Data, context and methodology
The current picture for Ireland is built on the European Respiratory Virus Surveillance Summary (ERVISS), published weekly by the European Centre for Disease Prevention and Control (ECDC). the Health Protection Surveillance Centre (HPSC) via the ICGP-HSE sentinel GP network is the national public-health authority that feeds ERVISS with sentinel primary care and virology data.
ECDC ERVISS
ERVISS is ECDC's weekly pan-European surveillance summary for influenza, SARS-CoV-2 and RSV. National authorities, in Ireland's case the Health Protection Surveillance Centre (HPSC) via the ICGP-HSE sentinel GP network, submit harmonised indicators every week, which ECDC publishes in a standardised dataset on Thursdays. Using ERVISS rather than each country's native portal ensures cross-country comparability.
ILI / ARI consultation rates and positivity
the Health Protection Surveillance Centre (HPSC) via the ICGP-HSE sentinel GP network operates a sentinel network of general practices that report weekly rates of patients consulting for influenza-like illness (ILI) or acute respiratory infection (ARI). A subset of patients is swabbed and tested by reference laboratories, producing pathogen-specific positivity rates for flu, SARS-CoV-2 and RSV.
Why this source
Combining consultation incidence with virological positivity yields a pathogen-specific weekly incidence signal (ILI × positivity / 100). This is the standard European methodology and provides a more robust view than either indicator alone: consultation rates capture illness burden, positivity confirms which pathogen is driving it.
Qualitative classification
The “low”, “moderate” and “high” categories follow seasonal reference values and epidemiological thresholds calibrated to match our classifications for other countries. The ILI × positivity / 100 product is scaled to comparable thresholds using a divisor of 3, which aligns European sentinel peaks with the consultation-equivalent scale used elsewhere. Data refreshes weekly when ECDC publishes the latest ERVISS update, typically on Thursdays.
Source and seasonal pattern by pathogen
- Influenza
- The classification is based on the ECDC ERVISS weekly reports, drawing on data from the Health Protection Surveillance Centre (HPSC) via the ICGP-HSE sentinel GP network. Seasonally, infection waves in Ireland typically peak between December and February; activity is usually markedly lower during the summer months.
- COVID-19
- The classification is based on the ECDC ERVISS weekly reports, drawing on COVID-19 surveillance data from the Health Protection Surveillance Centre (HPSC) via the ICGP-HSE sentinel GP network. Seasonally, infection waves in Ireland typically peak during winter, with occasional summer waves driven by new variants; activity is usually markedly lower in late spring between waves.
- RSV
- The classification is based on the ECDC ERVISS weekly reports, drawing on RSV surveillance data from the Health Protection Surveillance Centre (HPSC) via the ICGP-HSE sentinel GP network. Seasonally, infection waves in Ireland typically peak between December and February; activity is usually markedly lower in spring and summer.
Frequently asked questions
When is RSV season in Ireland?
RSV in Ireland typically returns in late autumn, rises through November and December, and peaks between December and February before fading in spring. Post-pandemic seasons have been less predictable than pre-2020 patterns, with earlier onset in some years. HPSC tracks RSV activity within its weekly Respiratory Viruses Report alongside flu and SARS-CoV-2.
Who is most at risk from RSV in Ireland?
The groups at highest risk of severe RSV are infants (especially those under six months, preterm babies, and children with underlying heart or lung disease) and older adults, particularly those aged 75 and above or with chronic respiratory or cardiac conditions. RSV is the leading cause of bronchiolitis hospitalisations in Irish infants. In otherwise healthy children and adults, RSV usually resembles a common cold.
Are RSV vaccines available in Ireland?
Since 2023, RSV vaccines have been authorised in the EU for older adults, and the long-acting monoclonal antibody nirsevimab is available for infants. Ireland has progressively introduced nirsevimab for infants entering their first RSV season, with administration through maternity hospitals, and adult RSV vaccination for defined risk groups under National Immunisation Advisory Committee (NIAC) guidance. HPSC monitors uptake and paediatric hospitalisation trends.
How is RSV surveillance organised in Ireland?
Irish RSV surveillance combines sentinel-laboratory testing, sentinel GP data, and hospital-admission signals coordinated by the Health Protection Surveillance Centre. Virological characterisation is performed at the National Virus Reference Laboratory. Weekly results feed HPSC's Respiratory Viruses Report and ECDC ERVISS, which makes Ireland's RSV curve directly comparable with the UK and EU/EEA neighbours.
How does RSV differ from flu in Irish data?
In HPSC's respiratory panel, flu and RSV appear as distinct positivity streams. RSV disproportionately affects infants and the very elderly and is the main driver of paediatric bronchiolitis admissions in Ireland, while flu burden spreads across age bands and is especially severe in older adults. Symptom overlap is wide, so the distinction relies on laboratory testing rather than clinical impression.
More situation reports
Data last refreshed: Aug 31, 2026, 11:11. Update cadence: weekly.
This page is not medical advice and does not replace consultation with a healthcare professional. For specific symptoms, please contact a medical professional.
About this page
Published by Renderei Martin GmbH, Berlin. No commercial interest in individual health recommendations. The app is optionally monetised via a freemium subscription.
Content is based exclusively on the linked official surveillance publications. Medical statements are curated against the guidance of RKI, ECDC and WHO.
Methodology enquiries: press@infectrisk.com